|
"wen fang cheng"的相關文件
顯示項目 406-415 / 485 (共49頁)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T05:48:33Z |
Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
|
Lin, H.-H. and Cheng, W.-F. and Chan, K.-W.A. and Chang, D.-Y. and Chen, C.-K. and Huang, S.-C.; WEN-FANG CHENG; HO-HSIUNG LIN |
| 臺大學術典藏 |
2018-09-10T05:48:32Z |
Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix
|
Ho, C.-M. and Cheng, W.-F. and Chu, T.-Y. and Chen, C.-A. and Chuang, M.-H. and Chang, S.-F. and Hsieh, C.-Y.; CHI-AN CHEN; WEN-FANG CHENG |
| 臺大學術典藏 |
2018-09-10T05:48:32Z |
Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis
|
Cheng, W.-F.;Chen, L.-K.;Chen, C.-A.;Chang, M.-C.;Hsiao, P.-N.;Su, Y.-N.;Lee, C.-N.;Jeng, H.-J.;Hsieh, C.-Y.;Sun, W.-Z.; PO-NI HSIAO; CHI-AN CHEN; WEN-FANG CHENG; CHIEN-NAN LEE; WEI-ZEN SUN; LI-KUEI CHEN |
| 臺大學術典藏 |
2018-09-10T05:48:32Z |
A rapid and reliable detection system for the analysis of PMP22 gene dosage by MP/DHPLC assay
|
Lin, C.-Y. and Su, Y.-N. and Lee, C.-N. and Hung, C.-C. and Cheng, W.-F. and Lin, W.-L. and Chen, C.-A. and Hsieh, S.-T.; CHI-AN CHEN; WEN-FANG CHENG; SUNG-TSANG HSIEH; CHIEN-NAN LEE |
| 臺大學術典藏 |
2018-09-10T05:48:31Z |
Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity
|
Cheng, W.-F. and Lee, C.-N. and Su, Y.-N. and Chai, C.-Y. and Chang, M.-C. and Polo, J.M. and Hung, C.-F. and Wu, T.-C. and Hsieh, C.-Y. and Chen, C.-A.; CHI-AN CHEN; WEN-FANG CHENG; CHIEN-NAN LEE |
| 臺大學術典藏 |
2018-09-10T05:46:33Z |
Prediction of residual neoplasia based on histopathology and margin status of conization specimens
|
Chang, D.-Y. and Cheng, W.-F. and Torng, P.-L. and Chen, R.-J. and Huang, S.-C.; RUEY-JIEN CHEN; PAO-LING TORNG; WEN-FANG CHENG |
| 臺大學術典藏 |
2018-09-10T05:33:04Z |
Antigen-specific CD8+T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Cheng, W.-F. and Lee, C.-N. and Chang, M.-C. and Su, Y.-N. and Chen, C.-A. and Hsieh, C.-Y.; CHI-AN CHEN; WEN-FANG CHENG; CHIEN-NAN LEE |
| 臺大學術典藏 |
2018-09-10T05:14:06Z |
Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis
|
Cheng, W.-F. and Hung, C.-F. and Chen, C.-A. and Lee, C.-N. and Su, Y.-N. and Chai, C.-Y. and Boyd, D.A.K. and Hsieh, C.-Y. and Wu, T.-C.; CHI-AN CHEN; WEN-FANG CHENG; CHIEN-NAN LEE |
| 臺大學術典藏 |
2018-09-10T05:14:06Z |
Leiomyosarcoma of the broad ligament: A case report and literature review
|
Cheng, W.-F. and Lin, H.-H. and Chen, C.-K. and Chang, D.-Y. and Huang, S.-C.; WEN-FANG CHENG; HO-HSIUNG LIN |
| 臺大學術典藏 |
2018-09-10T05:14:05Z |
Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects
|
Liao, C.-W. and Chen, C.-A. and Lee, C.-N. and Su, Y.-N. and Chang, M.-C. and Syu, M.-H. and Hsieh, C.-Y. and Cheng, W.-F.; CHI-AN CHEN; WEN-FANG CHENG; CHIEN-NAN LEE |
顯示項目 406-415 / 485 (共49頁)
<< < 36 37 38 39 40 41 42 43 44 45 > >>
每頁顯示[10|25|50]項目
|
